Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

• Status: Unknown status
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asociación para Evitar la Ceguera en México
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• Clinical diagnosis of Angioid Streaks

• Choroidal neovascularization associated

• Untreated patients or patients treated once with PDT

Exclusion Criteria:

• Ocular surgery excepting uncomplicated phacoemulsification

• Glaucoma or any other ocular pathology